NEW YORK, April 04, 2017 -- Patrick Luthy, Financial Controller of the Americas division of Medtronic, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Finance, Business, and Technology.
Medtronic is a medical device company that focuses on improving and transforming the lives of millions. Its mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments of application that alleviate pain, restore health, and extend life. Initially started as a medical equipment repair shop in 1949, Medtronic has expanded to include medical technologies from implantable mechanical devices, surgical instruments, and biologic delivery devices.
Mr. Luthy has been active in the healthcare industry for over two decades. He earned his Master’s degree in Commercial and Industrial Finance from the University of Geneva in 1993 and completed the International Marketing Program at INSEAD in 2004. He received his Leadership Certification in High Performance Leadership from the IMD Business School.
As the Financial Controller of the Americas division of Medtronic, Mr. Luthy leads budget and forecast submission processes for Canada and Latin America and provides C-suite executives with monthly and quarterly performance analysis on revenue and expenses. Additionally, he supervises revenue accruals related to rebates and other revenue adjustments for the USA.
Throughout his career, Mr. Luthy has led commercial go-direct strategy, setting up a new organization from the ground up that exceeded financial expectations and delivered significant incremental margin, and served as a key participant of two major and highly successful integrations while focusing on business continuity, talent retention, and system integration. He has developed and led high-performing teams, promoted key talents, encouraged cross-cultural experiences, and successfully executed key projects.
Looking back, Mr. Luthy attributes his success to a strong work ethic matched with working well with others and understanding that there are multiple solutions to a problem. He has provided strategic financial leadership and direction to the new Americas division at Medtronic following the acquisition of Covidien, transformed Latin American finance into a highly-respected business partner, and implemented ERPs across Latin America, thereby improving controls, automation, and process. Professionally Mr. Luthy maintains affiliation with the NAW-Miami, GAMD, and the Americas Society and Council of the Americas.
Considering the future, Mr. Luthy’s long-terms goals include continuing to act as a valuable finance business partner by driving growth in markets through partnership across functions, businesses, and geographies.
In his free time, Mr. Luthy enjoys mentoring others, especially regarding their career goals.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
AFT Leaves X Over AI-Generated Images of Minors
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 



